产前多种维生素和矿物质中选定的营养素和重金属的含量:一项观察性研究
Laura M Borgelt1, Michael Armstrong2, Stephen Brindley2
1Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, Unites States.
The American journal of clinical nutrition
|April 19, 2025
概括
产前多种维生素往往缺乏准确的胆和含量,许多产品含有未申报的重金属. 对于这些必需的食补充剂,需要更严格的联邦监管.
科学领域:
- 营养科学 营养科学
- 分析化学 分析化学
- 公共卫生 公共卫生
背景情况:
- 消费者对产前多种维生素和矿物质 (PMVMs) 的依赖程度很高.
- 准确的胆和对于胎儿发育至关重要.
- PMVM可能含有不准确的营养水平和有毒的重金属.
研究的目的:
- 为了评估非处方和处方PMVM的胆和含量.
- 为了评估PMVM中,和的存在.
主要方法:
- 在线和零售来源的47种PMVM产品的观察研究.
- 液态色谱仪质谱仪用于胆分析.
- 用于和重金属分析的感应合等离子体质谱.
主要成果:
- 在报告的74.4%的产品中,胆含量是不准确的.
- 在报告的84%的产品中,含量是不准确的.
- 在许多PMVM中检测到,和,但在USP限制内.
结论:
- 许多PMVM具有误导性或不准确的营养含量.
- 关键营养素的遗漏和重金属的存在是令人担忧的.
- 在美国,对食补充剂的联邦监管是必要的.
相关概念视频
Minerals
184
Minerals are essential nutrients that the human body needs in small amounts to work properly. They play a vital role in many bodily functions, such as building strong bones and transmitting nerve impulses. Some minerals are needed for hormone production or to maintain a normal heartbeat. Major minerals include calcium, phosphorus, potassium, sulfur, sodium, chlorine, and magnesium, while trace minerals include iron, manganese, copper, iodine, zinc, cobalt, fluoride, and selenium.
Major...
Major...
184
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.0K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.0K
Factors Influencing Bioavailability: First-Pass Elimination
5.8K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
5.8K
Preclinical Development: Overview
4.0K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.0K
The Periodic Table and Organismal Elements
172.6K
Overview
172.6K
Teratogenicity
2.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K


